AP-22161 selectively binds the Src SH2 domain by targeting highly conserved phosphotyrosine binding to cysteine residues in the pocket. AP-22161 selectively inhibits Src SH2 binding and can be used to inhibit osteoclast absorption.

268741-42-0

C32H39N3O7

577.67

G7VE62573J;AP 22161;UNII-G7VE62573J;AP22161;SCHEMBL7243003;AP-22161

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years